Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nilotinib with NOVE-HiDAC for c-kit positive AML
NCT01222143Phase 2Terminated
- Sponsor
- University Health Network
- Start
- Oct 2010
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nilotinib in acute myeloid leukemia (AML), sponsored by University Health Network. Started Oct 2010; status: terminated.
02
Drugs
nilotinib
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01222143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01222143.